Sangamo Therapeutics
SGMO
#8855
Rank
ยฃ0.11 B
Marketcap
ยฃ0.33
Share price
-0.13%
Change (1 day)
-62.25%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -ยฃ83.1 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ32.87 Million. In 2024 the company made an earning of -ยฃ73.34 Million, an increase over its 2023 earnings that were of -ยฃ88.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ83.1 Million13.3%
2024 -ยฃ73.34 Million-17.27%
2023 -ยฃ88.64 Million-40.88%
2022 -ยฃ0.15 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ96.51 Million23.17%
2019 -ยฃ78.36 Million36.33%
2018 -ยฃ57.48 Million36.89%
2017 -ยฃ41.99 Million-22.32%
2016 -ยฃ54.06 Million54.86%
2015 -ยฃ34.91 Million75.62%
2014 -ยฃ19.88 Million0.13%
2013 -ยฃ19.85 Million
2011 -ยฃ26.69 Million43.66%
2010 -ยฃ18.58 Million28.52%
2009 -ยฃ14.46 Million-23.55%
2008 -ยฃ18.91 Million2.45%
2007 -ยฃ18.46 Million19.5%
2006 -ยฃ15.45 Million50.78%
2005 -ยฃ10.25 Million75%
2004 -ยฃ5.86 Million-33.25%
2003 -ยฃ8.77 Million-62.27%
2002 -ยฃ23.24 Million102.82%
2001 -ยฃ11.46 Million23.21%
2000 -ยฃ9.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
ยฃ7.36 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ97.07 M-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.14 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.41 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ0.56 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.13 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.50 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.20 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA